Motegrity and Profen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Motegrity (prucalopride succinate) and Profen (ibuprofen). Common drug interactions include migraine among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Motegrity and Profen. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Motegrity?

Motegrity has active ingredients of prucalopride succinate. eHealthMe is studying from 1,380 Motegrity users. Check the latest studies of Motegrity.

What is Profen?

Profen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 245,311 Profen users. Check the latest studies of Profen.



On Jul, 20, 2026

29 people who take Motegrity and Profen together, and have interactions are studied.

Motegrity and Profen drug interactions.

What are the common drug interactions of Motegrity and Profen, by gender? *:

female:

  1. Migraine (headache)
  2. Asthma
  3. Constipation
  4. Foot fracture
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Neuroma (tumour of nerve tissue)
  7. Pain in extremity
  8. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  9. Pruritus (severe itching of the skin)
  10. Urticaria (rash of round, red welts on the skin that itch intensely)

male:

  1. Death
  2. Dizziness
  3. Dyspnoea (difficult or laboured respiration)
  4. Hallucination (an experience involving the perception of something not present)
  5. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  6. Somnolence (a state of near-sleep, a strong desire for sleep)
  7. Sputum discoloured

What are the common drug interactions of Motegrity and Profen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Asthma
  2. Foot fracture
  3. Hypoaesthesia (reduced sense of touch or sensation)
  4. Ligament sprain (ligament stretched)
  5. Lyme disease (a bacterial infection that is spread to humans by infected ticks)
  6. Neuroma (tumour of nerve tissue)
  7. Pain in extremity
  8. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  9. Pruritus (severe itching of the skin)
  10. Urticaria (rash of round, red welts on the skin that itch intensely)

30-39:

n/a

40-49:

  1. Headache (pain in head)
  2. Fungal infection
  3. Abdominal pain upper
  4. Pancreatitis (inflammation of pancreas)
  5. Viral pharyngitis (inflammation of the throat or pharynx caused by viral infection)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Migraine (headache)
  8. Nausea (feeling of having an urge to vomit)
  9. Vomiting
  10. Abdominal discomfort

50-59:

  1. Drug ineffective
  2. Death
  3. Injection site necrosis (death of body tissue at injection site)
  4. Muscle atrophy (a decrease in the mass of the muscle)
  5. Post procedural complication

60+:

  1. Dizziness
  2. Myalgia (muscle pain)
  3. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Sputum discoloured
  6. Vomiting
  7. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
  8. Diarrhoea
  9. Dyspnoea (difficult or laboured respiration)
  10. Ear discomfort

What are the existing conditions these people have? *

  1. Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer): 6 people, 20.69%
  2. Impaired Gastric Emptying: 4 people, 13.79%
  3. Immunodeficiency Common Variable: 4 people, 13.79%
  4. Autonomic Neuropathy (malfunction of the autonomic nervous system (ans)): 4 people, 13.79%
  5. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 10.34%
  6. Colon Cancer: 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Motegrity and Profen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Motegrity and Profen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Motegrity:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Profen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Motegrity and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Profen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on prucalopride succinate and ibuprofen (the active ingredients of Motegrity and Profen, respectively), and Motegrity and Profen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: